Cancer Family
Pleural Mesothelial Neoplasm
CI-CAN-00000322Explore in graph →
Non-malignant34 active trials4 approved drugs6 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000322Explore in graph →
Clinical trials
157 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01211275 | Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma(N08CPA) | completed | Phase 1 / Phase 2 | 32 | The Netherlands Cancer InstituteOTHER | 1 | Feb 28, 2017 | clinicaltrials |
| NCT00571298 | Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma | completed | Phase 1 | 141 | Brigham and Women's HospitalOTHER | 1 |
| Jan 23, 2017 |
| clinicaltrials |
| NCT02639767 | Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma | withdrawn | Phase 1 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT01212367 | Intrapleural Gene Transfer for Pleural Mesothelioma(IFN-alpha) | completed | Phase 1 | 13 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 22, 2015 | clinicaltrials |
| NCT00165555 | Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma | completed | Phase 1 | 70 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 27, 2014 | clinicaltrials |
| NCT01241682 | Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma(PMR-MM-002) | completed | Phase 1 | 10 | Erasmus Medical CenterOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT01353482 | A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma(MESO-02) | withdrawn | Phase 1 / Phase 2 | 0 | University College, LondonOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT00280982 | Dendritic Cell-based Immunotherapy in Mesothelioma | completed | Phase 1 | 10 | Erasmus Medical CenterOTHER | 1 | Nov 16, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Feb 28, 2017source: clinicaltrials